1 Gueugniaud PY, "Subarachnoid hemorrhage: a complication of CPR" 15 : 284-285, 1987
2 Galasko GI, "Subarachnoid haemorrhage presenting as acute myocardial infarction with electromechanical dissociation arrest" 86 : 340-, 2001
3 Samama MM, "New data on the pharmacology of heparin and low molecular weight heparins" 52 : 8-14, 1996
4 Frydman A, "Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans" 26 : 24-38, 1996
5 Weitz JI, "Low-molecular-Weight heparins" 337 : 688-698, 1997
6 Department of Pharmacy Freemantle Hospital, "Low molecular weight heparins in 1999" 23 : 12-17, 1999
7 Coock C, "Low molecular weight heparin and the risk of haemorrhage following percutaneous biopsy, despite a normal standard clotting screen" 11 : 2536-2538, 2001
8 Calvo-Romero JM, "Hemorrhagic transformation of ischemic stroke associated with enoxaparin and aspirin concomitant therapy" 18 : 77-78, 2004
9 Chan-Tack KM, "Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin" 96 : 58-60, 2003
10 Van Heerde M, "Fatal intracranial haemorrhage associated with the administration of low-molecular-weight heparin in a child" 164 : 589-590, 2005
1 Gueugniaud PY, "Subarachnoid hemorrhage: a complication of CPR" 15 : 284-285, 1987
2 Galasko GI, "Subarachnoid haemorrhage presenting as acute myocardial infarction with electromechanical dissociation arrest" 86 : 340-, 2001
3 Samama MM, "New data on the pharmacology of heparin and low molecular weight heparins" 52 : 8-14, 1996
4 Frydman A, "Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans" 26 : 24-38, 1996
5 Weitz JI, "Low-molecular-Weight heparins" 337 : 688-698, 1997
6 Department of Pharmacy Freemantle Hospital, "Low molecular weight heparins in 1999" 23 : 12-17, 1999
7 Coock C, "Low molecular weight heparin and the risk of haemorrhage following percutaneous biopsy, despite a normal standard clotting screen" 11 : 2536-2538, 2001
8 Calvo-Romero JM, "Hemorrhagic transformation of ischemic stroke associated with enoxaparin and aspirin concomitant therapy" 18 : 77-78, 2004
9 Chan-Tack KM, "Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin" 96 : 58-60, 2003
10 Van Heerde M, "Fatal intracranial haemorrhage associated with the administration of low-molecular-weight heparin in a child" 164 : 589-590, 2005
11 Noble S, "Enoxaparin: A review of its clinical potential in the management of coronary artery disease" 56 : 259-272, 1998
12 Gerlach AT, "Enoxaparin and bleeding complications: a review in patients with and without renal insufficiency" 20 : 771-775, 2000
13 Duplaga BA, "Dosing and monitoring of low-molecular-weight heparins in special populations" 218-234, 2001
14 Mackson J, "Doses of enoxaparin in patients with reduced renal function" 1998
15 Safar P, "Cerebral resuscitation after cardiac arrest: a review" 74 : 138-153, 1986
16 Chen JK, "Antioxidants and myocardial ischemia: reperfusion injuries" 28 : 369-377, 2005
17 Olson S, "Acute subdural haematomas and enoxaparin" 9 : 256-259, 2002
18 Oh DR, "Acute myocardial injury in subarachnoid hemorrhage: two cases reports" 5 : 93-99, 1994
19 Cohen M, "A comparison of low-molecularweight heparin with unfractionated heparin for unstable coronary artery disease" Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events Study Group 337 : 447-452, 1997